skip to Main Content

Innovative Therapy Strategy for Pancreatic Cancer Uses Engineered Exosomes Targeting Mutated KRAS Gene

Newsfeed image, light gray text on dark gray background
Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating pancreatic cancer, according to a study at The University of Texas MD Anderson Cancer Center.

Findings from the study, led by Valerie LeBleu, Ph.D., assistant professor of Cancer Biology, and Sushrut Kamerkar, Ph.D., assistant student in the MD Anderson UT Health Graduate School of Biomedical Sciences and the Cancer Biology Program, were published in the June 7 online issue of Nature. Read more . . .

Back To Top